孟鲁司特钠辅助阿奇霉素治疗小儿喘息性支气管炎的效果评价

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (30 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To evaluate the effect of Montelukast assisted Azithromycin in the treatment of pediatric asthmatic bronchitis.Methods A total of 120 children with asthmatic bronchitis treated in our hospital from January 2016 to October 2017 were selected as subjects and divided into the single drug group and combination group according to random number table method,60 in each group.The single drug group were given Azithromycin alone and the combination group was treated with Montelukast Sodium assisted Azithromycin.The therapeutic effect,symptom relief time,the index of hypersensitive C-reactive protein (hsCRP)and the incidence of adverse reactions of two groups were compared.Results After treatment,the total effective rate of the children in the combination group (95.00%)was higher than that of the single drug group(78.33%),and the difference was statistically significant(P＜0.05).The relief time of cough,wheezing,wheezing sound,the temperature dropped to the normal range and hospitalization days of the children in the combination group were significantly shorter than those in the single drug group,and the differences were statistically significant(P＜0.05).After treatment,two groups of children with hypersensitive C-reactive protein levels were lower than before treatment,and combination group with hypersensitive C-reactive protein levels were lower than that in the single drug groups,the differences were statistically significant(P＜0.05).The incidence of adverse reactions of the children in the combination group(3.33%)was lower than that of the single drug group(18.33%),and the difference was statistically significant(P＜0.05).Conclusion Montelukast Sodium is a good adjuvant for the treatment of asthmatic bronchitis,it can improve the clinical efficacy.The improvement of various symptoms is rapid,and the incidence of adverse reactions low,with safety and reliability.

Key words： Asthmatic bronchitis Montelukast Sodium Azithromycin Therapeutic effect Hypersensitive C-reactive protein Adverse reactions

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Zhen-ni
	XIAO Xiao-dong
	GONG Wei-ming

Cite this article:

WANG Zhen-ni,XIAO Xiao-dong,GONG Wei-ming. Effect evaluate of Montelukast Sodium assisted Azithromycin in the treament of pediatric asthmatic bronchitis[J]. 中国当代医药, 2018, 25(8): 129-131.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I8/129

[1]	张嫦娥.两种方法对小儿喘息性支气管炎的治疗效果[J].山西职工医学院学报，2017，27（4）：9-10.
[2]	钱超颖.孟鲁司特钠辅助治疗小儿喘息性支气管炎的临床疗效[J].包头医学院学报，2016，32（12）：86-87.
[3]	李亚.孟鲁司特钠联合三联雾化吸入治疗小儿喘息性支气管炎 60 例疗效分析[J].吉林医学，2017，38（9）：1622-1623.
[4]	王斌，吴静华，李永权，等.孟鲁司特钠治疗小儿喘息性支气管炎的疗效及对气道高反应性的预防效果分析[J].医学综述，2016，22（8）：1600-1602.
[5]	魏晓峰.孟鲁斯特治疗小儿喘息性支气管炎的临床观察[J].中国卫生标准管理，2016，7（3）：114-115.
[6]	刘顺伟.孟鲁司特钠治疗小儿喘息性支气管炎患儿的临床效果[J].医疗装备，2017，30（3）：12-13.
[7]	吴丽萍.孟鲁司特钠治疗小儿喘息性支气管炎的临床分析[J].当代医学，2017，23（11）：108-109.
[8]	许志伟，贝为豪，刘沛，等.孟鲁司特钠联合阿奇霉素治疗小儿喘息性支气管炎疗效观察[J].吉林医学，2017，38（3）：413-414.
[9]	赵家艳.孟鲁司特钠治疗小儿喘息性支气管炎患儿气道高反应性的效果观察[J].当代诊断与治疗，2017，28（9）：1656-1657.
[10]	张景丽，张彦霞，吴晓杰，等.孟鲁司特钠治疗毛细支气管炎急性发作后反复喘息的临床效果及对患儿免疫功能的影响分析[J].中国医学前沿杂志，2017，9（4）：60-63.
[11]	屠岩.孟鲁司特钠治疗儿童呼吸道合胞病毒感染毛细支气管炎患儿的临床效果[J].医疗装备，2017，30（22）：88-89.
[12]	郑亚文，崔智亮，程卡米，等.小儿喘息性支气管炎应用孟鲁司特钠治疗的价值分析[J].中国当代医药，2016，23（30）：91-93.
[13]	付俊建，周春.孟鲁司特钠联合阿奇霉素对喘息性支气管炎患儿临床症状及CRP水平的影响[J].临床研究，2017，31（9）：164-170.
[14]	廖先辉，林世飞.孟鲁司特钠联合阿奇霉素治疗小儿喘息性支气管炎的临床疗效[J].儿科药学杂志，2016，22（7）：24-27.
[15]	李艳娜.孟鲁司特钠治疗小儿喘息性支气管炎的效果及其对机体气道高反应性的改善作用分析[J].河南医学研究，2017，26（16）：2971-2972.